Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. Training and development programs almost universally focus factory-like on inputs and outputs — absorb curriculum, check a box; learn a skill, advance a rung; submit to assessment, fix a problem.

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.

Globalization 13

Globalization Marketing Venture Capitalist Biotechnology 13

Harvard Business Review

MARCH 1, 2011

And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice. And biotechnology and medical devices are among the leading areas for venture capital funding. Virtually every day, there is information about a clinical study with a new way to treat sick people.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Develop Creative Discontent. Three major factors drive convergence: technology, competition, and the customer.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8